Mason Morfit takes charge at ValueAct — 13 years after being tipped
Son of a diplomat has reputation as activist hedge fund manager companies can love
Becoming chief executive of the activist investing fund ValueAct Capital has not been without its physical challenges for Mason Morfit. The firm’s founder, Jeff Ubben, tried to make him swim in a glacier lake in Montana to make him partner. James Gorman, Morgan Stanley’s chief executive, challenged him to a rowing fitness contest, after the fund took a stake in the bank.
The 44-year-old has become accustomed to being challenged.
“Mason walked in off the street when he was 25,” Mr Ubben said. “He was a Princeton friend of an analyst who worked with me before ValueAct, and . . . I was just looking for a warm body. I got about three months of free work from him.”
Mr Morfit spent the following years travelling around the country with Mr Ubben to “crash analyst meetings together” and helping to run the business when Mr Ubben was forced to spend much of his time focusing on ValueAct’s sizeable investment in Martha Stewart Living when its founder was charged with insider trading.
This week Mr Morfit took the reins for real, as Mr Ubben relinquished the chief executive title to become chairman. The moment had been a long time coming. As early as 2007, Mr Ubben told Mr Morfit he would be his eventual successor, and a decade later, he handed over daily oversight of ValueAct’s portfolio, giving Mr Morfit the chief investment officer title.
“In 2007 he was the youngest person on the team but he was also the one who was going to take the reins because he was very comfortable with risk,” Mr Ubben said. “And the funny thing is, everybody saw it, too. We weren’t huge back then, we probably had four investment partners, five analysts. When I said that Mason was the successor, [there was] just zero pushback.”
Mr Morfit, the son of a US diplomat, was raised in India and Indonesia before his family moved to Washington when he was in junior high. He attended Sidwell Friends, a Quaker school that counts the children of former presidents from Theodore Roosevelt to Barack Obama as alumni, then Princeton University. He was working in New York as a research analyst at Credit Suisse when he was introduced to Mr Ubben.
Mr Morfit’s influence can be seen in the fund’s four biggest current stakes: Morgan Stanley and Citigroup, private equity giant KKR and Seagate Technology, a data storage company, said Mr Ubben. The firm’s Master fund was up about 32 per cent last year, roughly in line with the return on the S&P 500, enough to make ValueAct one of the best-performing shareholder activists.
“It’s a bull market so everyone feels smart, but I think the stocks we own are going up for a reason,” Mr Ubben said. “And this was his call, it’s his portfolio. And he made those choices and I think ValueAct would be in a very different place without him.”
ValueAct pioneered a constructive style of activism, shunning public battles in favour of gaining board seats and working with management to turn round companies they think are undervalued. The fund may be pushing even harder away from the “activist” label with Mr Morfit at the helm.
John Thompson, the chairman of the board at Microsoft, said that when ValueAct became a shareholder in 2013, the technology group’s then chief executive Steve Ballmer was trying to negotiate his departure privately and “the last thing we wanted was an activist investor joining our board”.
Mr Thompson got in touch with a former director at Valeant, the pharmaceuticals company where ValueAct was then a shareholder, to ask about their experience with the firm.
“They said it’s not about the firm but it’s about who from the firm becomes involved,” Mr Thompson recalled. “And he said the person from the firm you want is Mason Morfit.”
The Microsoft board negotiated a deal with ValueAct that they could join the board after Mr Ballmer’s successor was decided, and that the seat would go to Mr Morfit.
In one of his early meetings with ValueAct, Mr Thompson said he was “pleasantly surprised” to find Mr Morfit “less violently opinionated” than Mr Ubben. Mr Thompson was also impressed that when the new director started lobbying for changes around capital allocation early on in the tenure of Mr Ballmer’s successor, Satya Nadella, Mr Morfit agreed with Mr Thompson’s request to be patient first.
In a recent interview, Mr Morfit said he wants ValueAct to be viewed as a shareholder that companies which are going through change want to have on their share register.
Executives at some of the companies ValueAct is invested in said they have appreciated Mr Morfit’s input.
Mike Corbat, chief executive of Citigroup, said he first spoke to ValueAct when the fund got in touch to say they were building up a position in the bank.
“We did our homework around ValueAct and Mason in particular and his reputation,” said Mr Corbat. “I think he’s a good listener, I think he’s been very good and fair. He doesn’t waste our time on things, and he’s not only wanted to know about our business but he’s gone out of his way to learn about our people and our leadership.”
Scott Nuttall, the co-president and co-chief operating officer of private equity giant KKR, said he and Mr Morfit have bonded over growing up in founder-led organisations where the reins are slowly being handed over to them.
“One of the early meetings we had was with him, Henry [Kravis, KKR’s co-founder], Jeff [Ubben] and me,” Mr Nuttall said. “We were both navigating similar circumstances, trying to figure out how to build and lead a talent-based organisation where the founders were still part of the organisation.”
“We’ve developed a separate relationship about how do you do that,” Mr Nuttall added. “We’ve been through a lot of what they’re going through.”
Mr Morfit encouraged KKR to consider becoming the first of the major private equity firms to ditch its partnership structure in favour of becoming a corporation, a move that has helped boost its share price. KKR shares are up about 85 per cent since ValueAct first disclosed their stake.
Mr Ubben conceded that handing over to new leadership could be rocky for a hedge fund. Investors have been “watching” through the handover to see how it would work out, and it has seen shrinkage in its assets.
“Most firms don’t go through a transition, they tend to convert to a family office, so I would say the investor response is generally patient but certainly not willing to increase their bet with us,” he said.